Bain Capital Public Equity Management II’s Dynavax Technologies DVAX Stock Holding History

Bain Capital Public Equity Management II’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-219,800	Closed	-$2.17M	–	55
2021 Q2	$2.17M	Sell	219,800 -81,000	-27%	-$736K	0.09%	37
2021 Q1	$2.96M	Buy	300,800 +171,888	+133%	+$1.42M	0.12%	51
2020 Q4	$574K	Hold	128,912	–	–	0.03%	41
2020 Q3	$557K	Sell	128,912 -775,567	-86%	-$5.53M	0.04%	38
2020 Q2	$8.03M	Sell	904,479 -1,977,557	-69%	-$9.99M	0.62%	30
2020 Q1	$10.2M	Sell	2,882,036 -677,511	-19%	-$3.14M	1.19%	21
2019 Q4	$20.4M	Buy	3,559,547 +214,201	+6%	+$1.15M	1.93%	18
2019 Q3	$12M	Buy	3,345,346 +2,040,000	+156%	+$7.91M	1.14%	26
2019 Q2	$5.21M	Buy	+1,305,346	New	+$7.57M	0.48%	35

Other funds holding DVAX

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Bain Capital Public Equity Management II's DVAX Position: Q3 2021 in Review

Bain Capital Public Equity Management II sold out of Dynavax Technologies (DVAX) in Q3 2021, closing a stake of 219,800 shares — an estimated $2.17M sold.

Bain Capital Public Equity Management II first reported a position in DVAX in Q2 2019 and held it in 9 quarters. The position peaked at $20.4M in Q4 2019. 183 funds tracked by Wall St. Rank hold DVAX as of Q3 2021.

Bain Capital Public Equity Management II reported no remaining Dynavax Technologies position as of Q3 2021 after selling out during the quarter.
Bain Capital Public Equity Management II sold 219,800 Dynavax Technologies shares in Q3 2021, an estimated $2.17M.
Bain Capital Public Equity Management II first reported a position in Dynavax Technologies in Q2 2019 and held it in 9 quarters.
Bain Capital Public Equity Management II's Dynavax Technologies position peaked at $20.4M in Q4 2019.
183 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2021.

Based on Bain Capital Public Equity Management II's 13F filing for Q3 2021, filed 15 Nov 2021.